Simplicity Wealth’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPT
MVM
O
TCM
FCMV
RI
CG
BI
NCM
ACM
Simplicity Wealth's RAPT Position: Q2 2025 in Review
Simplicity Wealth sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 2,536 shares — an estimated $24.7K sold.
Simplicity Wealth first reported a position in RAPT in Q1 2025 and held it in 1 quarter. The position peaked at $24.7K in Q1 2025. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.
- Simplicity Wealth reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
- Simplicity Wealth sold 2,536 RAPT Therapeutics shares in Q2 2025, an estimated $24.7K.
- Simplicity Wealth first reported a position in RAPT Therapeutics in Q1 2025 and held it in 1 quarter.
- Simplicity Wealth's RAPT Therapeutics position peaked at $24.7K in Q1 2025.
- 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.
Based on Simplicity Wealth's 13F filing for Q2 2025, filed 22 Jul 2025.